Second Sight Medical Products Inc - Warrants (14/03/2024

(Warrants)
NAS:EYESW (USA)   Warrants (14/03/2024)
$ 0.22 0 (0%) 09:42 AM EST
At Loss
P/B:
0.86
Volume:
1.30K
Avg Vol (2M):
-
Volume:
1.30K
At Loss
Avg Vol (2M):
-

Business Description

Second Sight Medical Products Inc
NAICS : 339112 SIC : 3842

Share Class Description:

EYESW: Warrants (14/03/2024)
Compare
Compare
SONXLUCDLHDXLNSRAZYOVAPOCFMSISOCTSOMOVEABTMDTSYKEWBSXSZSE:300760DXCMZBHSTEALGN
Traded in other countries / regions
IPO Date
2017-03-29
Description
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 373.36
Equity-to-Asset 0.96
Debt-to-EBITDA -0.02
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 22.15
Quick Ratio 22.15
Cash Ratio 21.76

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -60.4
Shareholder Yield % 1.85

Profitability Rank

Name Current Vs Industry Vs History
ROE % -13.37
ROA % -12.79
ROIC % -201.17
ROC (Joel Greenblatt) % -2650.52
ROCE % -13.46

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 0.86
EV-to-EBIT 0.2
EV-to-EBITDA 0.2
EV-to-FCF 0.2
Earnings Yield (Greenblatt) % 500
FCF Yield % -17.36

Financials (Next Earnings Date:2024-05-16 Est.)

EYESW's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:EYESW

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Second Sight Medical Products Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) 0
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % 0
52-Week Range ($) 0 - 1.26
Shares Outstanding (Mil)

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Second Sight Medical Products Inc Filings

Filing Date Document Date Form
No Filing Data

Second Sight Medical Products Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Second Sight Medical Products Inc Frequently Asked Questions

What is Second Sight Medical Products Inc(EYESW)'s stock price today?
The current price of EYESW is $0.22. The 52 week high of EYESW is $1.26 and 52 week low is $0.00.
When is next earnings date of Second Sight Medical Products Inc(EYESW)?
The next earnings date of Second Sight Medical Products Inc(EYESW) is 2024-05-16 Est..
Does Second Sight Medical Products Inc(EYESW) pay dividends? If so, how much?
Second Sight Medical Products Inc(EYESW) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1